Photo of Emma Guttman

Emma Guttman

  • ASSOCIATE PROFESSOR Dermatology
  • ASSOCIATE PROFESSOR Medicine, Clinical Immunology
Print ProfilePrint Profile

Specialty

Certifications

  • American Board of Dermatology

Clinical Focus

Education

  • MD, Sackler School of Medicine

  • Internship, Rotating
    Meir Hospital

  • Residency, Dermatology
    Rambam Health Care Campus

  • Internship, Internal Medicine
    Memorial Sloan-Kettering Cancer Center

  • Residency, Dermatology
    Weill Cornell Medical College

Biography

    Emma Guttman-Yassky, MD, PhD is an Associate Professor of Dermatology & Immunology and Director of the center for Excellence in Eczema and the Occupational/Contact Dermatitis clinic and the Director of the Laboratory of Inflammatory Skin Diseases in the Department of Dermatology at the Icahn School of Medicne at Mount Sinai in New York. She earned her M.D. degree from Sackler School of Medicine at the Tel-Aviv University, and a Ph.D. degree from the Bar-Ilan University Ramat-Gan, Israel. Dr. Guttman completed her first dermatology residency at the Dermatology Department at the Rambam Medical Center/Technion Institute in Haifa. After obtaining her Israeli Board certification in dermatology, Dr. Guttman moved to the U.S. to pursue a two-year postdoctoral fellowship at The Rockefeller University in the Laboratory for Investigative Dermatology. Upon completion of her fellowship, she became board-certified by the American Board of dermatology after obtaining her second dermatology residency training at the Weill-Cornell Medical College, in NY. Dr. Guttman’s major clinical focus is in atopic dermatitis/eczema and contact/occupational dermatitis. She has done groundbreaking research and published extensively on inflammatory skin diseases. Emma Guttman is now the pre-eminent dermatologist studying molecular and cellular pathomechanisms of atopic dermatitis/eczema (AD) in humans, and made paradigm-shifting observations on its immunologic mechanisms, with important therapeutic implications, opening the door to new therapeutic discoveries. She has been the first to identify the importance of IL-22 cytokine in atopic dermatitis and has recently received a large NIAMS/NIH grant to study the therapeutic effects of blocking IL-22 in patients with eczema. 


    Her research made paradigm-shifting discoveries on the immunologic basis of atopic dermatitis/eczema (AD) in humans, enriching the understanding of the pathophysiology of this common disorder and opening the door to new therapeutic discoveries.  She is now testing novel therapeutics developed for eczema in clinical trials aimed to ultimately improve the quality of lives of patients with eczema. 


    She is the recipient of the prestigious Young Investigator Award (2011) from the American Academy of Dermatology, the 2011 recipient of the Dermatology Foundation’s Physician-Scientist Career Development Award, and the Everett C. Fox Award for best clinical research at the Residents & Fellows Symposium of the American academy of dermatology.


    Recently, Dr. Guttman has been awarded several important federal and foundation grants. She received a large NIH grant to do a proof of
    concept study on the role of Th22 T-cells in atopic dermatitis/eczema using a novel anti IL-22 antibody.


    She has also secured a grant from the LEO Foundation to study
    immune and terminal differentiation biomarkers in pediatric AD, as well as an
    award from theNational Institute of Allergy and Infectious Diseases (NIAID)
    to participate in a multi-center study on the role of infections in AD.
    Additionally, she received support from pharmaceutical companies, underscoring her recognition as an outstanding physician-scientist in the dermatology community. She is doing many mechanistic studies involving clinical trials with new therapeutics in patients atopic dermatitis around the globe.


    Her research on eczema has contributed directly to the recently developed treatments for this disease, earning her a unique place in dermatology and immunology worldwide. She is now invited to speak not only nationally, but also in Europe and Japan on novel developments in eczema and its therapeutics.

Awards

  • 2011 -
    Young Investigator Award (2011)
    American Academy of Dermatology

Research

Inflammatory Skin Diseases

st1:*{behavior:url(#ieooui) }

Dr. Guttman’s groundbreaking research focuses on atopic dermatitis/eczema and contact dermatitis. Her research has important implications in advancing the current molecular knowledge on atopic dermatitis/eczema and developing new therapeutics.

Dr. Guttman currently develops biomarkers of atopic dermatitis that could be used for future studies with targeted therapeutics. She also concentrates on unraveling the primary pathogenesis of this common disease.

st1:*{behavior:url(#ieooui) }

She is the recipient of the prestigious Young Investigator Award (2011) from the of Dermatology, the 2011 recipient of the Dermatology Foundation’s Physician-Scientist Career Development Award, and the recipient of the Fisher award of the American Contact Dermatitis Society 2011.


Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Guttman during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • Celgene Corporation; Merck & Co., Inc.; Regeneron Pharmaceuticals

Scientific Advisory Board:

  • Stiefel Laboratories, Inc., a GSK company

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Genentech, Inc.; LEO Pharma A/S; MedImmune, LLC

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Faculty Practice Associates Floor 5th Room Dermatology Suite
5 East 98th Street
New York, NY 10029

Tel: 212-241-9728

Address

Annenberg Building Floor 11th
1468 Madison Avenue
New York, NY 10029

Mount Sinai Dermatology Faculty Practice Associate

5 East 98 Street
5th Floor, Dermatology Suite
New York, NY 10029

Tel: 212-241-9728
Fax: 212-241-6690
Get Directions

Office Hours:
  • Monday 8:00am - 5:00pm
  • Wednesday 8:00am - 1:00pm
  • Thursday 8:00am - 1:00pm
Languages:
  • Hebrew
  • Romanian
  • Russian
  • Arabic
  • Spanish
Insurance Plans
  • 1199
  • Aetna
  • BCBS EPO
  • BCBS HMO
  • Blue Cross/ Blue Shield
  • CIGNA Select Source
  • Empire Blue Cross/ Blue Shield - HMO
  • Empire Blue Cross/Blue Shield
  • GHI
  • HIP (all products EXCEPT Medicaid)
  • Oxford (Medicare)
  • Oxford Freedom
  • Oxford Health Plans
  • Oxford Health Plans - HMO
  • Oxford Health Plans of New York
  • United Health - PPO
  • United Health Care - Mount Sinai Top Tier
  • United Health Care Empire Plan
  • United Healthcare - HMO
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Discover
  • Personal Check
  • Cash